GE HealthCare is leveraging AI and data integration technologies to help tackle the rapidly increasing volume of patient data and working to optimize the application of these two tech tools in patient care in announcing 40 new innovations at RSNA23. 

The company's central strategy is to integrate AI into its precision care framework, encompassing smart devices, targeted therapies, disease-specific focus and digital solutions, including its theranostics pathway manager, which aims to give providers a tool to coordinate oncology care and identify patients who could be potential theranostics candidates.

Another offering announced at RSNA23 by the medtech giant is SIGNA Champion, its 1.5T scanner utilizing AI to streamline workflows to support efficiency with high-quality images. 

GE HealthCare has amassed 58 FDA 510(k) clearances or authorizations for AI-enabled medical devices in the U.S.

The company also offers CardioVisio, an atrial fibrillation (AFib) patient-management dashboard designed to enhance clinical confidence and save time.

GE HealthCare said collaborations with Nuance and Microsoft have resulted in a research project exploring the automation of the assembly of pertinent prior studies for radiologists. This automation, in turn, can help optimize imaging workflows.

"Our vision encompasses a centralized patient view, uniting data within and beyond hospitals, furnishing real-time insights for informed treatment decisions," Dr. Taha Kass-Hout, chief technology officer at GE HealthCare, said in a statement. "With GE HealthCare, clinicians work smarter, not harder, affecting substantial change."

THE LARGER TREND

Philips announced the release of its BlueSeal MR Mobile at RSNA23, a transportable MRI system that can be placed within a truck. The scanner connects to Philips Radiology Operations Command Center, bringing remote imaging experts and technologists together via real-time video, audio or peer-to-peer text chat. 

GE HealthCare has been a big player in the theranostics space, which utilizes scanning technologies to combine therapeutics and diagnostics in order to advance oncology care.

Last month, the company announced a partnered with Michigan-based cancer-care center BAMF Health to bolster theranostics adoption by creating a framework to support scalable solutions that help advance precision medicine in the U.S.

In addition to expanding theranostics in oncology care, GE HealthCare has put effort into helping providers utilize data. 

The amount of health data collected has grown exponentially in the last decade, and the data deluge is forcing stakeholders in the health-data ecosystem to rethink design and scale their capabilities to unlock the full value of health data.

A staggering 30% of the world's data stems from the healthcare sector, yet a substantial 97% of data generated by hospitals remains untapped, according to a recent Deloitte survey.

An initiative from the Sequoia Project focuses on adopting the Data Usability Implementation Guide, which focuses on the interoperability of trustworthy, usable data in healthcare.